NEVRO CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.38 USD | +0.36% |
|
+5.28% | -61.06% |
| 07-01 | Nevro Corp.(NYSE:NVRO) added to Russell Microcap Value Index | CI |
| 07-01 | Nevro Corp.(NYSE:NVRO) dropped from Russell 2500 Growth Index | CI |
Presenter SpeechMichael Weinstein (Analysts)Hi, it's Mike Weinstein from JPMorgan. Welcome, ev...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.
Calendar
30/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
8.38
USD
Average target price
14.8
USD
Spread / Average Target
+76.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -61.06% | 307M | |
| -7.03% | 180B | |
| -6.32% | 99.21B | |
| -6.15% | 66.25B | |
| -10.62% | 44.74B | |
| +8.34% | 43.82B | |
| +10.35% | 41.96B | |
| +11.64% | 28.98B | |
| +16.18% | 24.07B | |
| -8.87% | 23.5B |
- Stock Market
- Equities
- NVRO Stock
- News Nevro Corp.
- Transcript : Nevro Corp. Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 11
